Damien Perriman's most recent trade in eXoZymes Inc. was a trade of 146,437 Stock Option for Common Stock done . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| eXoZymes Inc | Damien Perriman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 146,437 | 146,437 | - | - | Stock Option for Common Stock | |
| eXoZymes Inc | Damien Perriman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 62,759 | 62,759 | - | 0 | Restricted Stock Grant for Common Stock | |
| eXoZymes Inc | Damien Perriman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 8.44 per share. | 01 Apr 2026 | 8,887 | 0 | - | 8.4 | 75,006 | COMMON STOCK |